glp-1 probiotic pro Pendulum Gut Level GLP Akkermansia Pro GLP-1 Probiotic™ |

Drug-Metabolizing Enzyme- and Transporter- Mediated DDIs of GLP-1 RAs and a Dual GLP-1/GIP RA To date, no clinically relevant drug-metabolizing enzyme- or transporter-mediated DDIs involving GLP-1 RAs or a dual GLP-1/GIP RA have been reported (Table 3)

Atlas, S

AbdulMaksoud RS, Elsayed WSH, Rashad NM, Elsayed RS, Elshorbagy S, Hamed MG

Last year, a team of researchers at the Case Western Reserve University School of Medicine studied 1.6 million patients with type 2 diabetes and found that those on GLP-1 drugs had significant risk reduction of ten cancers: esophageal, colorectal, endometrial, gallbladder, kidney, liver, ovarian, and pancreatic cancer, as well as meningioma and multiple myeloma

In their study: Semaglutide was not detected in any of the milk samples (tested for up to 24 hours after the injection)